Because of NF-κB's central role in numerous cancer-related processes and involvement in risk of others cancers [23-26], we hypothesized that inherited variation in the genes encoding the key inhibitors IκBα and IκBβ (NFKBIA and NFKBIB, respectively) is associated with ovarian cancer risk. This evidence concerns the gene NFKBIB and cancer.